KURA
NASDAQ · Biotechnology
Kura Oncology Inc
$7.27
+0.47 (+6.91%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
+531.6% upside
Low Target
$25.11
Average Target
$45.92
High Target
$52.51
Current Price
$7.27
Current
$7.27
$7.27
Target
$45.92
$45.92
$25.11
$45.92 avg
$52.51
Scenario Analysis
Bear Case
$25.11
245.4%
Low target
Base Case
$45.92
+531.6%
Avg target
Bull Case
$52.51
+622.3%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$13.90
-47.7% from high
52-Week Low
$6.76
+7.5% from low
Target vs 52W High
$45.92
+230.4% vs high
Next Earnings Report
Nov 10, 2026 · After Market Close
Today
EPS Est: $-0.84
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.2% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -46.0% |
| REGN | Buy | 36 | 72% | $76.80 | -91.7% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -42.6% |